The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
21 minutes
Posted Oct 25, 2018 at 9:14 pm.
0:00
21:35
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?
Previous
Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
Next
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
← See all 424 episodes of The Readout Loud
